Dr Patrick Mcauliffe, PHD | |
24 Bailey Ave, Ridgefield, CT 06877-4555 | |
(203) 246-0000 | |
Not Available |
Full Name | Dr Patrick Mcauliffe |
---|---|
Gender | Male |
Speciality | Psychologist - Counseling |
Location | 24 Bailey Ave, Ridgefield, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609173665 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | 002943 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Mcauliffe, PHD 24 Bailey Ave, Ridgefield, CT 06877-4555 Ph: (203) 246-0000 | Dr Patrick Mcauliffe, PHD 24 Bailey Ave, Ridgefield, CT 06877-4555 Ph: (203) 246-0000 |
News Archive
Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces it has entered into a multi-step collaboration with XOMA Corporation, a leader in the discovery and development of therapeutic antibodies.
As of 30 January 2007, 411 suspected cases, including 121 deaths (case-fatality rate, 29%) have been reported in North Eastern Province, Coast Province, Eastern Province and Central Province. One hundred and thirty-one cases have been laboratory confirmed.
While social media has made connecting and communicating with anyone at any time as easy as pie, it also has altered teen's social skills and behaviors. Sites such as Facebook, Twitter and MySpace have proven to be great tools to expedite the development of empathy, encourage task-switching or even bring somewhat shy individuals a little more out of their shells. However, social media sites have also fostered a host of psychological and behavioral problems.
Vertex Pharmaceuticals Incorporated announced today that the European Commission has approved KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
The lack of protein TDP-43 in two neurodegenerative diseases is shown to prevent neuron growth via failed transport of RNA and subsequent absence of protein synthesis in axons
› Verified 8 days ago
Dr. David Rowe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 112 High Ridge Ave, Ridgefield, CT 06877 Phone: 646-828-6467 | |
Dr. Caley Schwartz, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 137 Ethan Allen Hwy, Suite 1, Ridgefield, CT 06877 Phone: 203-464-9053 | |
Dr. Joan W Whittemore, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 80 Grove Street, Ridgefield, CT 06877 Phone: 203-431-9110 | |
Dr. Barbara Keefe, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 90 Grove St, Suite 206, Ridgefield, CT 06877 Phone: 203-438-0426 | |
Elizabeth Courtney-seidler, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 100b Danbury Road, Suite 105b, Ridgefield, CT 06877 Phone: 203-297-8583 | |
Julia Cockerill, MSED, NCSP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 71 Prospect St, Ridgefield, CT 06877 Phone: 914-539-0277 | |
Dr. Yvette Tola Thompson, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 62 Rock Rd, Ridgefield, CT 06877 Phone: 203-244-5200 Fax: 203-244-5200 |